Status:

RECRUITING

Osteogenon in Orthopedics and Traumatology

Lead Sponsor:

University of Opole

Conditions:

Patients With Fractures

Eligibility:

All Genders

18-85 years

Phase:

PHASE4

Brief Summary

The aim of this study was to evaluate the supportive effect of the ossein-hydroxyapatite complex in fracture healing. The investigators hypothesized that the ossein-hydroxyapatite complex would positi...

Detailed Description

The role of ossein-hydroxyapatite complex in fracture healing requires further research. The aim of the study was to evaluate the effect of ossein-hydroxyapatite complex (Osteogenon) as an adjunctive...

Eligibility Criteria

Inclusion

  • no contraindications to taking Osteogenon
  • a follow-up period of more than 3 months after treatment completion
  • complete medical and radiological records
  • a written informed consent
  • not taking any other medications that could affect bone tissue remodeling
  • not taking other medications that interact with Osteogenon
  • no other limb pathologies (inflammatory or neurogenic)
  • absence of comorbidities that could affect bone union

Exclusion

  • age under 18 years or over 85 years
  • hypersensitivity to the active ingredient or to any of the excipients
  • severe renal failure and dialysis therapy
  • hypercalcemia
  • hypercalciuria
  • calcium-based kidney stones or tissue calcifications
  • a follow-up period shorter than 3 months after treatment completion
  • a lack of informed consent
  • a lack of cooperation with the patient
  • absent or incomplete medical and radiological records
  • taking medications that could affect bone tissue remodeling
  • taking medications that may interact with Osteogenon (e.g. thiazide diuretics)
  • metabolic disorders
  • post-traumatic skeletal deformities
  • neuromuscular disorders
  • post-inflammatory deformities

Key Trial Info

Start Date :

November 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2027

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT07210281

Start Date

November 1 2024

End Date

December 30 2027

Last Update

November 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Clinical Hospital in Opole

Opole, Opole Voivodeship, Poland, 46-020